The Hematopathology Team: from Slide to Strategy 

In episode 9, we are joined by Dr. Philip Kuriakose and Dr. Juan Gomez-Gelvez, who analyse how collaboration within hematopathology drives optimal patient care.

Dr. Philip Kuriakose, MD is a Hematology Medical Oncologist and the Medical Director of the Hemophilia and Thrombosis Treatment Center at Henry Ford Health.

Dr. Juan Gomez-Gelvez, MD is a Hematopathologist, Molecular Pathologist and the Section Head of Molecular Hematopathology also at Henry Ford Health.

The Better Testing, Better Treatment Podcast series

We are excited to announce that our ninth episode is now available!

That’s where DXRX comes in. More than just a platform, DXRX offers a gateway to growth by providing lab technicians with access to high-quality educational resources, peer collaboration, and real-world insights that help them stay ahead in a rapidly evolving field.

Enhance your professional skills and earn CPD credits from our LabTalks, tailored to boost technical expertise and career progression.

Share insights with our global network of labs and learn from real-world testing practices

Keep up to date with evolving lab techniques, regulatory standards, and best practices through curated industry newsletters

Whether it's mastering biomarker testing or understanding the latest innovations in precision medicine, DXRX empowers technicians to build confidence, expand their expertise, and take their careers to the next level.

Take a moment to search through DXRX and our resources on blood cancer.

LabTalks

In the dynamic world of haemato-oncology, lab technicians are the steady hands behind every test result. From preparing blood samples to running complex diagnostic assays, they play a crucial role in supporting accurate diagnoses and guiding treatment decisions for patients with blood cancers. Yet, despite their importance, technicians often face limited access to structured learning pathways and career development opportunities.

Lab directors' leadership is critical in the field of blood cancers. They oversee complex workflows, ensure regulatory compliance, and foster collaboration across departments. But with increasing demands and rapid technological change, lab directors need more than expertise; they need support.

DXRX: A Platform for Innovation and Collaboration

DXRX is designed to meet the evolving needs of lab leaders. It’s a collaborative platform that connects labs with biopharma, technology providers, and peers to accelerate diagnostic development and implementation.

Stay ahead of the curve with biomarker dashboards to inform and benchmark your lab’s performance against industry standards. 

Sign up to view dashboards

Gain strategic insights from LabTalk sessions covering the latest in emerging biomarkers, evolving testing algorithms, clinical guideline updates, and regulatory frameworks like IVDR and LDTs. 

Chronic Myeloid Leukemia  the essential role of molecular testing as a guide to diagnosis and treatment

Build your network and share expertise through our collaborative community, while keeping your team informed with curated education and the latest industry developments. 

Sign up to view collaborations

Lab directors are the driving force behind accurate, timely, and innovative blood cancer diagnostics. With platforms like DXRX, they’re not just keeping pace—they’re leading the way. This month, we celebrate their leadership, their impact, and their unwavering commitment to better patient care.

Explore the campaign and discover how DXRX is powering the future of diagnostics.

Blood Cancer Awareness Month is a time to honour the people who make life-saving diagnostics possible. At the heart of this effort are lab directors, visionary leaders who guide teams, implement cutting-edge technologies, and ensure the highest standards of testing.

Yet, with increasing diagnostic complexity and mounting pressure on lab resources, pathologists face significant challenges in delivering consistent, high-quality care. These challenges are where DXRX can be utilised, offering a collaborative platform designed to support pathologists with real-time clinical decision tools, streamlined workflows, and access to a global network of expertise.

Benefits of a DXRX membership for a Pathologist:

Access a rich library of white papers to support diagnostic accuracy and innovation in your practice. 

IVDR Updates

Collaborate through peer-reviewed ring studies to benchmark your performance against peers and identify areas of improvement 

Sign up to view our Collaborations

Stay engaged with the latest research and expert perspectives through our podcast series, designed to bring cutting-edge science and case discussions directly to you. 

Listen now

As the demands on haemato-oncology labs continue to grow, pathologist’s expertise in interpreting diagnostic data, guiding treatment decisions, and collaborating across clinical teams is central to delivering precision medicine in blood cancer care. DXRX offers not only a collaborative space that supports clinical decision making, but also bridges the gaps between data, diagnostics, and decision-making, empowering pathologists to deliver faster and more accurate care.

Join us this Blood Cancer Awareness month in celebrating the ‘Team behind the testing’. Shining a light on the laboratory professionals who are the foundation of diagnosis and treatment, working in the background to drive the success of precision medicine in blood cancer.

In the fast-evolving landscape of haemato-oncology, pathologists are a central part within the laboratory team who work tirelessly to ensure accurate diagnosis, guide targeted therapies and collaborate with other stakeholders to guarantee optimal, co-ordinated care. Their role is more critical than ever, as precision medicine demands deeper insights and faster turnaround times.

The Pathology-Oncology Connection: Labs in Action

Episode 8 of the 'Better Testing, Better Treatment' podcast welcomes our special guests, Dr. Chandler Park, co-director of GU cancer clinical trials at Norton Cancer Institute, and Dr. Sameer Talwalkar, board-certified Hematopathologist and Molecular Pathologist at CPA Lab, Norton Healthcare.

Dr. Park and Dr. Talwalkar to discuss how tailored testing and clear communication have led to better diagnostic and treatment decisions. The conversation also explores how the relationship between the lab and oncologist was built and how they navigate this through advancing treatment options.

We are excited to announce that our eighth episode is now available!

Insights

The Hematopathology Team: from Slide to Strategy

Building Expertise in the Lab: DXRX and the Evolving Role of Technicians in Haemato-Oncology

Leadership in Blood Cancer Diagnostics: How DXRX empowers Lab Directors to innovate and lead.

Elevating Pathology in Blood Cancer Care: The DXRX Advantage in Collaborative Diagnostics

The Pathology-Oncology Connection: Labs in Action